TY - JOUR T1 - Quantitative Evaluation of Myocardial Blood Flow and Ejection Fraction with a Single Dose of <sup>13</sup>NH<sub>3</sub> and Gated PET JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 999 LP - 1005 VL - 43 IS - 8 AU - Hidehiko Okazawa AU - Masaaki Takahashi AU - Tatsuhiko Hata AU - Kanji Sugimoto AU - Yoshihiko Kishibe AU - Takafumi Tsuji Y1 - 2002/08/01 UR - http://jnm.snmjournals.org/content/43/8/999.abstract N2 - To evaluate myocardial blood flow (MBF) and cardiac function with a single dose of 13NH3, electrocardiographically (ECG) gated PET acquisition was performed after a dynamic PET scan was obtained. Gated blood-pool (GBP) imaging with C15O PET was also performed to compare the left ventricular ejection fraction (LVEF) obtained using the 2 methods. Methods: Six healthy volunteers and 34 patients with cardiovascular disease were studied. Each subject underwent dynamic PET scanning after a slow intravenous injection of approximately 740 MBq 13NH3, followed by ECG gated PET scanning. MBF images were calculated by the Patlak plot method. Before obtaining the 13NH3 scan, the GBP image was obtained with a bolus inhalation of C15O. Twenty patients also underwent left ventriculography (LVG) to compare the value of the LVEF obtained using this technique with that determined using the gated PET method. Results: The mean regional value of MBF calculated for healthy volunteers in the resting condition was 0.61 ± 0.10 mL/min/g. The LVEF obtained using GBP PET (EFCO) was consistent with that obtained using LVG. The LVEF calculated from gated 13NH3 scans (EFNH3) correlated well with EFCO, although EFNH3 slightly underestimated the LVEF (EFNH3 = 0.97 · EFCO − 2.94; r = 0.87). EFNH3 was significantly different from EFCO in patients with a perfusion defect in the cardiac wall (EFNH3 = 39% ± 11% vs. EFCO = 45% ± 11%; n = 19; P &lt; 0.001), whereas no significant difference was found between them in subjects with no defect (EFNH3 = 58% ± 13% vs. EFCO = 61% ± 10%; n = 21). Conclusion: Gated PET acquisition accompanied by obtaining a dynamic PET scan with a single dose of 13NH3 is a promising method for the simultaneous clinical evaluation of MBF and cardiac function. However, in patients with a defect in the cardiac wall, EFNH3 showed a tendency to underestimate the EF compared with EFCO. ER -